Cardiac lipidomics, a burgeoning field within cardiovascular research, focuses on the comprehensive study of lipid molecules in the heart. Lipids, essential components of cell membranes, play a pivotal role in maintaining cellular structure and function. In the context of cardiac health, lipidomics investigates the intricate lipid composition of cardiac tissues and aims to unravel their dynamic roles in physiological and pathological conditions. Understanding the lipidomic profile of the heart provides insights into lipid metabolism, signaling pathways, and their impact on cardiac diseases, including atherosclerosis and heart failure. Researchers in cardiac lipidomics employ advanced analytical techniques to characterize lipid species, paving the way for innovative diagnostic and therapeutic strategies to address cardiovascular disorders. This interdisciplinary approach at the intersection of lipid biochemistry and cardiology holds promise for uncovering novel biomarkers and potential therapeutic targets, contributing to advancements in cardiovascular medicine.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India